Investors (Bkp)
Overview
Impact Biomedical drives mission-oriented discovery and research to development new treatment options and products in specialty biopharmaceuticals and consumer healthcare.
We specialize in partnering with companies across three biomedical industry sectors: Biotech/Med-tech, Consumer Wellness/Direct Marketing/OTC, and Emerging Technology. Our partners and investors are dedicated to discover and enhance biopharmaceutical technologies and products to address unmet needs in human healthcare.
Our biopharmaceutical technologies have potential to advance treatment in oncology, neurology, and immunology. Consumer efforts include naturally based sugar alternatives fragrances and insect repellents, as well antibacterial, antiviral, and antimicrobial technologies. A true spirit and desire of continuous improvement in healthcare result in continuous discovery of new technologies.
Stock Data
SEC Filings
Sorry, there is no data available.
Investor FAQ
Yes, the common stock of DSS, Inc. is traded on the NYSE/MKT LLC Exchange.
Yes, the common stock of DSS, Inc. is traded on the NYSE/MKT LLC Exchange.
Yes, the common stock of DSS, Inc. is traded on the NYSE/MKT LLC Exchange.
Download our
Annual and Investor Reports
View our annual and investor reports for additional information on Impact BioMedical.
Press releases
Committee Charters
Governance Documents
Latest news
BioQuest – Race the Sun -news
Global Research and Discovery Group works with Impact BioMedical to advise the development of biodefense applications.
Healthier Sugar Unveiled at Harvard Health Summit
Global Research and Discovery Group unveiled healthier sugar at the Harvard Global Health Catalyst Summit, as they work […]
In Search of Ghosts
Our research team scours the biodiversity and botanical Orchid specimens of the Everglades in search of the next […]
Fox 13 News – Laetose™ Healthier Sugar
A Polk County scientist, Daryl Thompson of Global Research and Discovery Group, talks about the benefits of Laetose™, […]